Theravance Biopharma, Inc. (TBPH) › Shares OutstandingTheravance Biopharma, Inc. (TBPH) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2013: 02014: 32.22M2015: 37.98M2016: 52.83M2017: 54.38M2018: 55.68M2019: 57.02M2020: 64.33M2021: 74.44M2022: 65.23M2023: 48.09M2024: 49.47M2025: 51.07M51.07M2013Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY202551.07M+3.2%202449.47M+2.9%202348.09M-26.3%202265.23M-12.4%202174.44M+15.7%202064.33M+12.8%201957.02M+2.4%201855.68M+2.4%201754.38M+2.9%201652.83M+39.1%201537.98M+17.9%201432.22M—20130—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share